E.N.H. Jansen

5.6k total citations
33 papers, 1.2k citations indexed

About

E.N.H. Jansen is a scholar working on Neurology, Cellular and Molecular Neuroscience and Cognitive Neuroscience. According to data from OpenAlex, E.N.H. Jansen has authored 33 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Neurology, 9 papers in Cellular and Molecular Neuroscience and 7 papers in Cognitive Neuroscience. Recurrent topics in E.N.H. Jansen's work include Parkinson's Disease Mechanisms and Treatments (24 papers), Neurological disorders and treatments (15 papers) and Botulinum Toxin and Related Neurological Disorders (6 papers). E.N.H. Jansen is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (24 papers), Neurological disorders and treatments (15 papers) and Botulinum Toxin and Related Neurological Disorders (6 papers). E.N.H. Jansen collaborates with scholars based in Netherlands, Germany and Austria. E.N.H. Jansen's co-authors include Rob A. I. de Vos, Heiko Braak, Eva Braak, Deniz Yilmazer‐Hanke, J. Böhl, Teus van Laar, Cees Neef, K. A. Jellinger, H. Bratzke and R. A. C. Roos and has published in prestigious journals such as New England Journal of Medicine, Biological Psychiatry and Acta Neuropathologica.

In The Last Decade

E.N.H. Jansen

33 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E.N.H. Jansen Netherlands 17 782 363 289 193 170 33 1.2k
Antony J. Harding Australia 15 653 0.8× 319 0.9× 444 1.5× 250 1.3× 214 1.3× 22 1.3k
S. Weisenbach Germany 11 819 1.0× 346 1.0× 240 0.8× 312 1.6× 185 1.1× 12 1.3k
Heidi Cartwright Australia 15 976 1.2× 659 1.8× 258 0.9× 264 1.4× 249 1.5× 17 1.5k
Alexandra Gaenslen Germany 20 1.0k 1.3× 285 0.8× 278 1.0× 156 0.8× 240 1.4× 30 1.4k
Tatyana D. Fedorova Denmark 20 1.0k 1.3× 373 1.0× 272 0.9× 220 1.1× 130 0.8× 37 1.4k
J. Parkinson Canada 5 679 0.9× 282 0.8× 127 0.4× 104 0.5× 137 0.8× 11 939
Carrie G. Markgraf United States 16 491 0.6× 434 1.2× 164 0.6× 156 0.8× 310 1.8× 28 1.5k
Emmanuelle Pourcher Canada 21 1.0k 1.3× 485 1.3× 85 0.3× 243 1.3× 129 0.8× 49 1.6k
Natalie Thomas United Kingdom 8 394 0.5× 434 1.2× 351 1.2× 167 0.9× 118 0.7× 10 1.2k
F Santangelo Italy 16 197 0.3× 190 0.5× 136 0.5× 199 1.0× 175 1.0× 49 947

Countries citing papers authored by E.N.H. Jansen

Since Specialization
Citations

This map shows the geographic impact of E.N.H. Jansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.N.H. Jansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.N.H. Jansen more than expected).

Fields of papers citing papers by E.N.H. Jansen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E.N.H. Jansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.N.H. Jansen. The network helps show where E.N.H. Jansen may publish in the future.

Co-authorship network of co-authors of E.N.H. Jansen

This figure shows the co-authorship network connecting the top 25 collaborators of E.N.H. Jansen. A scholar is included among the top collaborators of E.N.H. Jansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E.N.H. Jansen. E.N.H. Jansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jansen, E.N.H.. (2009). Clozapine in the treatment of tremor in Parkinson's disease. Acta Neurologica Scandinavica. 89(4). 262–265. 24 indexed citations
2.
Jansen, E.N.H., et al.. (2009). Primary cerebellar nocardiosis and alveolar proteinosis. Acta Neurologica Scandinavica. 97(2). 138–141. 18 indexed citations
3.
Hoogendijk, Witte J.G., Jan S. Purba, Michel A. Hofman, et al.. (1998). Depression in Parkinson's disease is not accompanied by more corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus. Biological Psychology. 43. 913–917. 8 indexed citations
4.
Braak, Heiko, Rob A. I. de Vos, E.N.H. Jansen, H. Bratzke, & Eva Braak. (1998). Chapter 20 Neuropathological hallmarks of Alzheimer's and Parkinson's diseases. Progress in brain research. 267–285. 116 indexed citations
5.
Hoogendijk, Witte J.G., Jan S. Purba, Michel A. Hofman, et al.. (1998). Depression in Parkinson’s disease is not accompanied by more corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus. Biological Psychiatry. 43(12). 913–917. 11 indexed citations
6.
Braak, Heiko, Eva Braak, Deniz Yilmazer‐Hanke, et al.. (1996). New aspects of pathology in Parkinson’s disease with concomitant incipient Alzheimer’s disease. PubMed. 48. 1–6. 24 indexed citations
7.
Braak, Heiko, Eva Braak, Deniz Yilmazer‐Hanke, et al.. (1996). Pattern of brain destruction in Parkinson's and Alzheimer's diseases. Journal of Neural Transmission. 103(4). 455–490. 249 indexed citations
8.
Vos, Rob A. I. de, et al.. (1995). ‘Lewy body disease’: clinico-pathological correlations in 18 consecutive cases of Parkinson's disease with and without dementia. Clinical Neurology and Neurosurgery. 97(1). 13–22. 53 indexed citations
9.
Schröder, Hannsjörg, E.N.H. Jansen, Andrea Wevers, et al.. (1995). Gene expression of the nicotinic acetylcholine receptor α4 subunit in the frontal cortex in Parkinson's disease patients. Neuroscience Letters. 187(3). 173–176. 17 indexed citations
10.
Laar, Teus van, E.N.H. Jansen, Cees Neef, Meindert Danhof, & R. A. C. Roos. (1995). Pharmacokinetics and clinical efficacy of rectal apomorphine in patients with Parkinson's disease: A study of five different suppositories. Movement Disorders. 10(4). 433–439. 34 indexed citations
11.
Braak, Heiko, Eva Braak, Deniz Yilmazer‐Hanke, et al.. (1994). Amygdala pathology in Parkinson's disease. Acta Neuropathologica. 88(6). 493–500. 236 indexed citations
12.
Laar, Teus van, et al.. (1993). A double-blind study of the efficacy of apomorphine and its assessment in ‘off’-periods in Parkinson's disease. Clinical Neurology and Neurosurgery. 95(3). 231–235. 47 indexed citations
13.
Jansen, E.N.H., et al.. (1992). Parlodel SRO in Parkinson’s Disease: A Double-Blind Randomized Comparison of Parlodel Standard and Parlodel SRO. European Neurology. 32(6). 318–320. 7 indexed citations
14.
Wolters, E.Ch., M.W.I.M. Horstink, R. A. C. Roos, & E.N.H. Jansen. (1992). Clinical efficacy of sinemet CR 50/200 versus sinemet 25/100 in patients with fluctuating parkinson's disease. Clinical Neurology and Neurosurgery. 94(3). 205–211. 10 indexed citations
15.
Jennekens, F.G.I., et al.. (1992). Deficiency of acetylcholine receptors in a case of end‐plate acetylcholinesterase deficiency: A histochemical investigation. Muscle & Nerve. 15(1). 63–72. 18 indexed citations
16.
Laar, Teus van, et al.. (1992). Intranasal Apomorphine in Parkinsonian On-Off Fluctuations. Archives of Neurology. 49(5). 482–484. 39 indexed citations
17.
Jansen, E.N.H., et al.. (1989). Ischialgia caused by a malignant triton tumour of the lumbosacral plexus. Clinical Neurology and Neurosurgery. 91(2). 177–180. 1 indexed citations
18.
Jansen, E.N.H. & J. D. Meerwaldt. (1988). Madopar HBS in Parkinson patients with nocturnal akinesia. Clinical Neurology and Neurosurgery. 90(1). 35–39. 19 indexed citations
19.
Jansen, E.N.H., et al.. (1987). Open Multicenter Trial with Madopar HBS in Parkinsonian Patients. European Neurology. 27(1). 88–92. 4 indexed citations
20.
Haan, Joost, et al.. (1987). Falling Spells in Normal Pressure Hydrocephalus: A Favourable Prognostic Sign?. European Neurology. 27(4). 216–220. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antony J. Harding Breakdown of academic impact, for papers by S. Weisenbach Breakdown of academic impact, for papers by Heidi Cartwright Breakdown of academic impact, for papers by Alexandra Gaenslen Breakdown of academic impact, for papers by Tatyana D. Fedorova Breakdown of academic impact, for papers by J. Parkinson Breakdown of academic impact, for papers by Carrie G. Markgraf Breakdown of academic impact, for papers by Emmanuelle Pourcher Breakdown of academic impact, for papers by Natalie Thomas Breakdown of academic impact, for papers by F Santangelo
Rankless by CCL
2026